AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
+4.14%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$100M
AUM Growth
+$100M
(-25%)
Cap. Flow
-$37.3M
Cap. Flow
% of AUM
-37.26%
Top 10 Holdings %
Top 10 Hldgs %
26.12%
Holding
294
New
64
Increased
34
Reduced
105
Closed
85
Top Buys
| 1 |
Eli Lilly
LLY
|
$4.74M |
| 2 |
UnitedHealth
UNH
|
$3.6M |
| 3 |
Johnson & Johnson
JNJ
|
$2.63M |
| 4 |
AbbVie
ABBV
|
$2.31M |
| 5 |
Thermo Fisher Scientific
TMO
|
$2.17M |
Top Sells
| 1 |
Rithm Capital
RITM
|
$4.32M |
| 2 |
Harmony Biosciences
HRMY
|
$3.88M |
| 3 |
Galapagos
GLPG
|
$3.12M |
| 4 |
EFC
Ellington Financial
EFC
|
$2.6M |
| 5 |
Neurocrine Biosciences
NBIX
|
$2.57M |
Sector Composition
| 1 | Healthcare | 54.58% |
| 2 | Real Estate | 7.4% |
| 3 | Industrials | 5.96% |
| 4 | Financials | 5.87% |
| 5 | Technology | 4.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Graphic Packaging
GPK
$6.5B
| $1.09M | 1.08% |
+40,000
| New | +$1.09M |
|
27
Abbott
ABT
$229B
| $1.06M | 1.05% |
+9,333
| New | +$1.06M |
|
28
Pfizer
PFE
$142B
| $1.03M | 1.03% |
38,807
+3,807
| +11% | +$101K |
|
29
Elevance Health
ELV
$72.6B
| $997K | 0.99% |
+2,702
| New | +$997K |
|
30
Gilead Sciences
GILD
$140B
| $976K | 0.97% |
10,562
+7,062
| +202% | +$652K |
|
31
Danaher
DHR
$146B
| $958K | 0.96% |
+4,175
| New | +$958K |
|
32
Genworth Financial
GNW
$3.47B
| $937K | 0.93% |
+134,000
| New | +$937K |
|
33
Becton Dickinson
BDX
$53.9B
| $892K | 0.89% |
+3,930
| New | +$892K |
|
34
AtriCure
ATRC
$1.8B
| $796K | 0.79% |
+26,035
| New | +$796K |
|
|
CTO
35
CTO Realty Growth
CTO
$561M
| $788K | 0.79% |
+40,000
| New | +$788K |
|
|
VRNA
36
Verona Pharma
VRNA
$9.18B
| $753K | 0.75% |
16,211
-33,789
| -68% | -$1.57M |
|
37
AMREP Corp
AXR
$111M
| $719K | 0.72% |
+22,899
| New | +$719K |
|
38
Rockwell Automation
ROK
$38B
| $714K | 0.71% |
2,500
+250
| +11% | +$71.4K |
|
|
CIM
39
Chimera Investment
CIM
$1.14B
| $700K | 0.7% |
50,000
+35,978
| +257% | +$504K |
|
40
Accuray
ARAY
$153M
| $693K | 0.69% |
350,000
| – | – |
|
41
Edwards Lifesciences
EW
$48B
| $691K | 0.69% |
+9,333
| New | +$691K |
|
42
Exact Sciences
EXAS
$9.09B
| $662K | 0.66% |
11,790
-18,210
| -61% | -$1.02M |
|
43
Procept Biorobotics
PRCT
$2.2B
| $644K | 0.64% |
8,000
| – | – |
|
44
Rocket Lab Corporation Common Stock
RKLB
$23.8B
| $637K | 0.64% |
25,000
+10,000
| +67% | +$255K |
|
45
Encompass Health
EHC
$12.5B
| $635K | 0.63% |
+6,877
| New | +$635K |
|
46
Zimmer Biomet
ZBH
$20.8B
| $623K | 0.62% |
+5,895
| New | +$623K |
|
47
Stryker
SYK
$149B
| $619K | 0.62% |
+1,719
| New | +$619K |
|
48
NVIDIA
NVDA
$4.16T
| $582K | 0.58% |
4,335
-1,646
| -28% | -$221K |
|
49
SmartRent
SMRT
$275M
| $569K | 0.57% |
+325,000
| New | +$569K |
|
50
Hologic
HOLX
$14.8B
| $549K | 0.55% |
+7,614
| New | +$549K |
|